Corbus Pharmaceuticals PT maintained at $35 by HC Wainwright
HC Wainwright & Co. maintained its $35.00 per share price target for Corbus Pharmaceuticals,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.